PHILADELPHIA PHARMACEEUTICALS

To: Jordan Securities Commission,

ﺔﻴﻟﺎﻤﻟﺍ ﻕﺍﺭﻭﻻﺍ ﺔﺌﻴﻫ ﺓﺩﺎﺴﻟﺍ

Amman Stock Exchange

ﻥﺎﻤﻋ ﺔﺻﺭﻮﺑ ﺓﺩﺎﺴﻟﺍ

Company's Name: PHILADELPHIA PHARMACEEUTICALS

ﺔﻳﻭﺩﻷﺍ ﺔﻋﺎﻨﺼﻟ ﺎﻴﻔﻟﺩﻼﻴﻓ :ﺔﻛﺮﺸﻟﺍ ﻢﺳﺍ

Date: 15-03-2023 10:25:17 AM

AM 10:25:17 2023-03-15 :ﺦﻳﺭﺎﺘﻟﺍ

Subject: Distributing Dividends

ﺡﺎﺑﺭﺍ ﻊﻳﺯﻮﺗ :ﻉﻮﺿﻮﻤﻟﺍ

PHILADELPHIA PHARMACEEUTICALS announces that its

ﺎﻬﺗﺭﺍﺩﺇ ﺲﻠﺠﻣ ﺭﺍﺮﻗ ﻦﻋ ﺔﻳﻭﺩﻷﺍ ﺔﻋﺎﻨﺼﻟ ﺎﻴﻔﻟﺩﻼﻴﻓ ﺔﻛﺮﺷ ﻦﻠﻌﺗ

Board of Directors approved on 12-03-2023 the

ﺔﺌﻴﻬﻠﻟ ﺔﻴﺻﻮﺘﻟﺍ ﻰﻠﻋ ﺔﻘﻓﺍﻮﻤﻟﺎﺑ 2023-03-12 ﺦﻳﺭﺎﺘﺑ ﺬﺨﺘُﻤﻟﺍ

recommendation to the company's general assembly to:-

-:ﺔﻛﺮﺸﻠﻟ ﺔﻣﺎﻌﻟﺍ

Distributing cash dividends equal to 6% of the company's

ﻝﺎﻣ ﺱﺃﺭ ﻦﻣ %6 ﺔﺒﺴﻨﺑ ﻦﻴﻤﻫﺎﺴﻤﻟﺍ ﻰﻠﻋ ﺔﻳﺪﻘﻧ ﺡﺎﺑﺭﺍ ﻊﻳﺯﻮﺘﺑ

paid in capital 7500000 to shareholders

7500000 ﻎﻟﺎﺒﻟﺍﻭ ﻉﻮﻓﺪﻤﻟﺍ ﺔﻛﺮﺸﻟﺍ

Please accept our sincere thanks and appreciation.

.ﻡﺍﺮﺘﺣﻻﺍ ﻖﺋﺎﻓ ﻝﻮﺒﻘﺑ ﺍﻮﻠﻀﻔﺗﻭ

Chairman of Board of Directors

ﺓﺭﺍﺩﻹﺍ ﺲﻠﺠﻣ ﺲﻴﺋﺭ

User Name: Belal Salameh

Belal Salameh :ﻡﺪﺨﺘﺴﻤﻟﺍ ﻢﺳﺍ

This decision is subject to the company's General

ﺔﻛﺮﺸﻠﻟ ﺔﻣﺎﻌﻟﺍ ﺔﺌﻴﻬﻟﺍ ﺔﻘﻓﺍﻮﻤﻟ ﺭﺍﺮﻘﻟﺍ ﺍﺬﻫ ﻊﻀﺨﻳ

Assembly Approval

Page 1 of 1

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Philadelphia Pharmaceuticals Industry Co. PSC published this content on 15 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 March 2023 07:39:03 UTC.